AAAAAA

   
Results: 1-9 |
Results: 9
Deciding when to institute terminal palliative care for AIDs patients - anevidence based approach
Authors: Maartens, G Bekker, LG Sanne, I
Citation: G. Maartens et al., Deciding when to institute terminal palliative care for AIDs patients - anevidence based approach, S AFR MED J, 91(7), 2001, pp. 559-560
Adherence to antiretroviral therapy - Achievable in the South African context?
Authors: Orrell, C Bekker, LG Wood, R
Citation: C. Orrell et al., Adherence to antiretroviral therapy - Achievable in the South African context?, S AFR MED J, 91(6), 2001, pp. 483-484
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways
Authors: Bekker, LG Freeman, S Murray, PJ Ryffel, B Kaplan, G
Citation: Lg. Bekker et al., TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways, J IMMUNOL, 166(11), 2001, pp. 6728-6734
Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role
Authors: Schoeman, JF Springer, P Ravenscroft, A Donald, PR Bekker, LG van Rensburg, AJ Hanekom, WA Haslett, PAJ Kaplan, G
Citation: Jf. Schoeman et al., Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role, J CHILD NEU, 15(8), 2000, pp. 497-503
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
Authors: DeBarber, AE Mdluli, K Bosman, M Bekker, LG Barry, CE
Citation: Ae. Debarber et al., Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis, P NAS US, 97(17), 2000, pp. 9677-9682
Correction of defective host response to Mycobacterium bovis BCG infectionin TNF-deficient mice by bone marrow transplantation
Authors: Jacobs, M Marino, MW Brown, N Abel, B Bekker, LG Quesniaux, VJF Fick, L Ryffel, B
Citation: M. Jacobs et al., Correction of defective host response to Mycobacterium bovis BCG infectionin TNF-deficient mice by bone marrow transplantation, LAB INV, 80(6), 2000, pp. 901-914
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. (vol 181, pg 954, 2000)
Authors: Bekker, LG Haslett, P Maartens, G Steyn, L Kaplan, G
Citation: Lg. Bekker et al., Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. (vol 181, pg 954, 2000), J INFEC DIS, 181(4), 2000, pp. 1521-1521
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis
Authors: Bekker, LG Haslett, P Maartens, G Steyn, L Kaplan, G
Citation: Lg. Bekker et al., Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis, J INFEC DIS, 181(3), 2000, pp. 954-965
Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent
Authors: Bekker, LG Moreira, AL Bergtold, A Freeman, S Ryffel, B Kaplan, G
Citation: Lg. Bekker et al., Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent, INFEC IMMUN, 68(12), 2000, pp. 6954-6961
Risultati: 1-9 |